You have 9 free searches left this month | to do more

enzalutamide

Enzalutamide is a drug used to treat Prostate Cancer, Castration-Resistant Prostate Carcinoma, Prostatic Neoplasms, and other conditions. Enzalutamide is being actively studied in 111 studies and prior, has been studied in 58.

Top SponsorsTop SitesTop Investigators
PfizerMemorial Sloan Kettering Cancer CenterJulie Graff
Astellas Pharma Global Development, Inc.Dana Farber Cancer InstituteMamta Parikh
Astellas Pharma IncDuke University Medical CenterMary-Ellen Taplin, MD
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
E
Not yet recruiting
  • Prostate Cancer
  • Enzalutamide
  • EPI-7386 with Enzalutamide
  • Port Saint Lucie, Florida
  • +1 more
2021-10-07
Oct 7, 2021
N
Active, not recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • Prostate Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2021-09-11
Sep 11, 2021
Z
Recruiting
  • Metastatic Castration-Resistant Prostate Cancer
  • Baton Rouge, Louisiana
  • +1 more
2021-09-28
Sep 28, 2021
U
Completed
  • Prostate Cancer
  • Radium Ra 223 Dichloride
  • Enzalutamide
  • Salt Lake City, Utah
    Huntsman Cancer Institute
2020-10-05
Oct 5, 2020
S
Recruiting
  • Castration Resistant Metastatic Prostate Cancer
  • Testosterone cypionate
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins University/Sidney Kimmel Cancer Center
2021-09-22
Sep 22, 2021
U
Active, not recruiting
  • Prostate Cancer
  • Enzalutamide
  • Metformin Hydrochloride
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
2021-08-16
Aug 16, 2021
G
Active, not recruiting
  • Metastatic Castrate-resistant Prostate (CRPC) Cancer
  • Villejuif, Val De Marne, France
    Gustave Roussy
2021-02-23
Feb 23, 2021
R
Recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • Enzalutamide
  • Nijmegen, Netherlands
  • +2 more
2021-07-11
Jul 11, 2021
I
Recruiting
  • Prostate Cancer
  • Castration-resistant Prostate Cancer
  • São Paulo, SP, Brazil
    Instituto do Câncer do Estado de São Paulo
2021-05-14
May 14, 2021
S
Active, not recruiting
  • Cancer of the Prostate
  • Prostate Cancer
  • Aarau, Switzerland
  • +15 more
2021-09-27
Sep 27, 2021
D
Active, not recruiting
  • Intermediate Risk Prostate Cancer
  • Enzalutamide
  • External Beam Radiation
  • Boston, Massachusetts
  • +2 more
2021-07-26
Jul 26, 2021
D
Active, not recruiting
  • Castration-resistant Prostate Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
2021-04-19
Apr 19, 2021
U
Terminated
  • Prostatic Neoplasms
  • Pelvic Nodal
  • Enzalutamide
  • +2 more
  • San Francisco, California
    University of California San Francisco
2021-09-14
Sep 14, 2021
R
Terminated
  • Clear Cell Renal Cell Carcinoma
  • Stage I Renal Cell Cancer
  • Enzalutamide
  • +2 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
2021-09-14
Sep 14, 2021
M
Recruiting
  • Metastatic Prostate Carcinoma
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
2021-03-17
Mar 17, 2021
T
Completed
  • Castration-resistant Prostate Cancer
  • Osaka, Japan
    Osaka City University Graduate School of Medicine
2021-09-08
Sep 8, 2021
H
Completed
  • Pancreatic Cancer
  • Enzalutamide
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2021-08-16
Aug 16, 2021
C
Recruiting
  • Prostate Cancer
  • Shatin, Hong Kong
    Prince of Wales Hospital
2021-08-03
Aug 3, 2021
H
Completed
  • Metastatic Castration Resistant Prostate Cancer
  • Changsha, China
    Medical Ethics Committee of Hunan Cancer Hospital
2020-10-30
Oct 30, 2020
M
Active, not recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Myrtle Beach, South Carolina
    Research Site
2021-08-30
Aug 30, 2021
M
Recruiting
  • Metastatic Prostate Carcinoma
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
2021-02-22
Feb 22, 2021
C
Completed
  • Prostate Cancer
  • Los Angeles, California
    Cedars Sinai Medical Center
2020-12-04
Dec 4, 2020